Page last updated: 2024-09-05

ancistrocladidine and Leishmaniasis

ancistrocladidine has been researched along with Leishmaniasis in 1 studies

*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bringmann, G; Faber, JH; Gulder, T; Kajahn, I; Moll, H; Pedersen, SE; Ponte-Sucre, A; Schultheis, M1

Other Studies

1 other study(ies) available for ancistrocladidine and Leishmaniasis

ArticleYear
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Alkaloids; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Cells, Cultured; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Fibroblasts; Isoquinolines; Leishmania major; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Molecular Structure; NIH 3T3 Cells; Nitric Oxide; Parasitic Sensitivity Tests

2007